Tissue Restoration & Recovery Research
KLOW 80mg
KLOW 80mg
Four targets. One consolidated recovery-research blend.
A four-component GHK-Cu, TB-500, BPC-157 and KPV blend built for multi-pathway research across tissue response, barrier biology and extracellular-matrix signalling.
- Documentation
- Check batch record
- Availability
- In stock
For qualified laboratory research only · Not for human or veterinary use
Why researchers choose it
The labelled formula brings together copper-peptide, thymosin-related, BPC-157 and alpha-MSH-derived research domains in one 80mg blend for comparative multi-pathway study.
Research focus
- Extracellular-matrix and copper-peptide research
- Tissue-response and cell-migration pathways
- Barrier and inflammatory-signalling models
Evidence snapshot
The exact blend has no established efficacy or synergy data. Findings associated with individual components do not prove a combined outcome for KLOW.
Best suited to
Verify the labelled composition against the matching lot record before comparative blend research.
Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.
